Company Seeks FDA Approval for MDMA as Treatment for PTSD

WEDNESDAY, Dec. 13, 2023 -- A California company is asking the U.S. Food and Drug Administration to consider approving MDMA (midomafetamine capsules) as a treatment for posttraumatic stress disorder (PTSD).When announcing the new drug application...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news